Loading...
Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools
Jahromi, Leila Pourtalebi Shahbazi, Mohammad Ali Maleki, Aziz Azadi, Amir Santos, Hélder A.
Jahromi, Leila Pourtalebi
Shahbazi, Mohammad Ali
Maleki, Aziz
Azadi, Amir
Santos, Hélder A.
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2021-01-01
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 18.73 MB
Other Titles
Abstract
Over the past decades, considerable attention has been dedicated to the exploitation of diverse immune cells as therapeutic and/or diagnostic cell‐based microrobots for hard‐to‐treat disorders. To date, a plethora of therapeutics based on alive immune cells, surface‐engineered immune cells, immunocytes’ cell membranes, leukocyte‐derived extracellular vesicles or exosomes, and artificial immune cells have been investigated and a few have been introduced into the market. These systems take advantage of the unique characteristics and functions of immune cells, including their presence in circulating blood and various tissues, complex crosstalk properties, high affinity to different self and foreign markers, unique potential of their on‐demand navigation and activity, production of a variety of chemokines/cytokines, as well as being cytotoxic in particular conditions. Here, the latest progress in the development of engineered therapeutics and diagnostics inspired by immune cells to ameliorate cancer, inflammatory conditions, autoimmune diseases, neurodegenerative disorders, cardiovascular complications, and infectious diseases is reviewed, and finally, the perspective for their clinical application is delineated.
Citation
Advanced Science,(2021), DOI:10.1002/advs.202002499.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Review
Language
en
Description
Series/Report no.
ISSN
EISSN
21983844
ISBN
ISMN
Gov't Doc #
Sponsors
Academy of Finland
License
Attribution 4.0 International